NEW YORK (GenomeWeb) – The National Heart Centre Singapore (NHCS) has tapped WuXi Nextcode to develop informatics solutions for studying cardiovascular disease in patients in Singapore and Southeast Asia

Under the terms of the agreement, WuXi Nextcode will develop a cloud-based data warehouse that will integrate whole-genome sequence, medical, and wearables data from patients with cardiovascular disease and from healthy controls who have been recruited by the NHCS.

Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.